Finance

Lists
HEAL:CNSX
Restart Life Sciences Corp
CAD 0,070
0,00%
(0,00) 1D
14 Okt., 16:00:00 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for HEAL...
Open
CAD 0,07
High
CAD 0,07
Low
CAD 0,07
Mkt. cap
4,36 m
Avg. vol.
21,76 k
Volume
5,80 k
52-wk high
CAD 0,14
52-wk low
CAD 0,07
EPS
-CAD 0,03
Open
CAD 0,07
High
CAD 0,07
Low
CAD 0,07
Mkt. cap
4,36 m
Avg. vol.
21,76 k
Volume
5,80 k
52-wk high
CAD 0,14
52-wk low
CAD 0,07
EPS
-CAD 0,03
News stories
From web sources and news partners
About Restart Life Sciences Corp
CEO-
Employees-
Founded2004
HeadquartersVancouver, Brits-Columbië, Kanada
Sector-
Websiterestartlife.co
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
134,55 k
331,16 k
Cost of goods sold
-
-
72,62 k
200,46 k
Cost of revenue
-
-
72,62 k
200,46 k
Research and development expenses
-
-
5,00 k
-3,75 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
167,38 k
308,52 k
256,02 k
426,52 k
Operating expense
167,84 k
309,00 k
372,83 k
1,10 m
Total operating expenses
167,84 k
309,00 k
445,44 k
1,30 m
Operating income
-167,84 k
-309,00 k
-310,89 k
-972,69 k
Other non operating income
1,61 k
-7,44 k
-8,37 k
-12,41 k
EBT including unusual items
-210,98 k
-157,32 k
-326,14 k
-1,02 m
EBT excluding unusual items
-166,23 k
-316,44 k
-319,59 k
-996,55 k
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-210,98 k
-157,32 k
-326,14 k
-1,02 m
Net profit margin
-
-
-242,39%
-307,00%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-540,00
-11,10 k
Net interest expenses
-
-
-540,00
-11,10 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-167,38 k
-308,52 k
-309,55 k
-971,36 k
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme